Abstract
Introduction: Attention deficit hyperactivity disorder (ADHD) is the most common psychiatric diagnosis in childhood and adolescence, with an estimated worldwide-pooled prevalence of 5,29%. The type of treatment depends on several factors. Psychopharmacological treatment entails undesirable side effects, with unclear long-term benefits, which has led the scientific community to investigate other therapeutic approaches, such as dietary interventions.
Method: The authors conducted a classical review on the current treatment recommended in individuals with ADHD diagnosis, their dietary patterns, as well as dietary factors possibly implicated in the etiology and treatment of this disorder. An extensive bibliographic research was carried out in the databases PubMed, The Cochrane Library and the National Guideline Clearinghouse.
Discussion: The most common dietary interventions in the case of ADHD are food supplementation diets (e.g. PUFAs, vitamins) and elimination diets. Supplementation with omega-3 PUFAs lacks further studies that can validate them as an effective therapeutic approach in this disorder. Also, regarding vitamin supplementation, studies are not consistent as to their role in the etiology of ADHD. Elimination diets are unclear as to the benefits provided in individuals with ADHD. Children with ADHD are less likely to engage in healthy lifestyle behaviors than non-ADHD youth.
Conclusion: There is no clear evidence that supports dietary interventions for the treatment of ADHD. The effects of unhealthy diet patterns in ADHD individuals are not yet fully understood and, like the general population, children with ADHD may benefit from a healthy lifestyle.
Keywords: Attention deficit hyperactivity disorder, diet, food, dietary patterns, diet therapy, etiology.
Graphical Abstract
[2]
APA; Diagnostic and statistical manual of mental disorders DSM-5., 5th ed.; American Psychiatric Association: Washington, DC. 2013.
[3]
Polanczyk, G.; de Lima, M.S.; Horta, B.L.; Biederman, J.; Rohde, L.A. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am. J. Psychiatry, 2007, 164(6), 942-948.
[4]
National Center for Biotechnology Information. Informed Health
Online: Attention deficit hyperactivity disorder (ADHD): Overview.. https://www.ncbi.nlm.nih.gov/books/NBK321129/ (Accessed
March 30, 2018).
[5]
De Sousa, A.; Kalra, G. Drug therapy of attention deficit hyperactivity disorder: Current trends. Mens Sana Monogr., 2012, 10(1), 45-69.
[6]
Shier, A.C.; Reichenbacher, T.; Ghuman, H.S.; Ghuman, J.K. Pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: Clinical strategies. J. Cent. Nerv. Syst. Dis., 2013, 5, 1-17.
[7]
U.S. Food and Drug Administration. Dealing with ADHD: What
You Need to Know. https://www.fda.gov/ForConsumers/ ConsumerUpdates/ucm269188.htm (Accessed June 30, 2018).
[8]
Lange, K.W. The treatment of attention deficit hyperactivity disorder has no proven long-term benefits but possible adverse effects. Mov. Nutr. Health Dis., 2017, 1, 11-25.
[9]
Schweren, L.; Hoekstra, P.; van Lieshout, M.; Oosterlaan, J.; Lambregts-Rommelse, N.; Buitelaar, J.; Franke, B.; Hartman, C. Long-term effects of stimulant treatment on ADHD symptoms, social-emotional functioning, and cognition. Psychol. Med., 2018, 13, 1-7.
[10]
Howard, A.L.; Robinson, M.; Smith, G.J.; Ambrosini, G.L.; Piek, J.P.; Oddy, W.H. ADHD is associated with a “Western” dietary pattern in adolescents. J. Atten. Disord., 2011, 15(5), 403-411.
[11]
Kanarek, R.B. Artificial food dyes and attention deficit hyperactivity disorder. Nutr. Rev., 2011, 69(7), 385-391.
[12]
Hurt, E.A.; Arnold, L.E.; Lofthouse, N. Dietary and nutritional treatments for attention-deficit/hyperactivity disorder: Current research support and recommendations for practitioners. Curr. Psychiatry Rep., 2011, 13, 323-332.
[13]
Millichap, J.G.; Yee, M.M. The diet factor in attention-deficit/hyperactivity disorder. Pediatrics, 2012, 129, 330-337.
[14]
Heilskov Rytter, M.J.; Andersen, L.B.; Houmann, T.; Bilenberg, N.; Hvolby, A.; Mølgaard, C.; Michaelsen, K.F.; Lauritzen, L. Diet in the treatment of ADHD in children - a systematic review of the literature. Nord. J. Psychiatry, 2015, 69(1), 1-18.
[15]
Wu, X.; Ohinmaa, A.; Veugelers, P.J. The influence of health behaviours in childhood on attention deficit and hyperactivity disorder in adolescence. Nutrients, 2016, 8(12), 788.
[http://dx.doi.org/10.3390/ nu8120788]
[http://dx.doi.org/10.3390/ nu8120788]
[16]
Lange, K.W. Dietary factors in the etiology and therapy of attention deficit/hyperactivity disorder. Curr. Opin. Clin. Metab. Care, 2017, 20(6), 464-469.
[17]
Colter, A.L.; Cutler, C.; Meckling, K.A. Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: A case-control study. Nutr. J., 2008, 7, 8.
[18]
Schuchardt, J.P.; Huss, M.; Stauss-Grabo, M.; Hahn, A. Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children. Eur. J. Pediatr., 2010, 169, 149-164.
[19]
Frensham, L.J.; Bryan, J.; Parletta, N. Influences of micronutrient and omega-3 fatty acid supplementation on cognition, learning, and behavior: methodological considerations and implications for children and adolescents in developed societies. Nutr. Rev., 2012, 70, 594-610.
[20]
Johnson, M.; Månsson, J.E.; Ostlund, S.; Fransson, G.; Areskoug, B.; Hjalmarsson, K.; Landgren, M; Kadesjö, B.; Gillberg, C. Fatty
acids in ADHD: plasma profiles in a placebo-controlled study of
Omega 3/6 fatty acids in children and adolescents Atten. Defic.
Hyperact. Disord, 2012, 4(4), 199-204. ClinicalTrials.gov registration
number: NCT01219309.
[21]
Grant, R.; Guest, J. Role of omega-3 PUFAs in neurobiological health. Adv. Neurobiol., 2016, 12, 247-274.
[22]
Patterson, E.; Wall, R.; Fitzgerald, G.F.; Ross, R.P.; Stanton, C. Health Implications of High Dietary Omega-6 Polyunsaturated Fatty Acids. J. Nutr. Metab., 2012, 2012, 539426.
[23]
Bos, D.J.; van Montfort, S.J.T.; Oranje, B.; Durston, S.; Smeets, P.A. Role of omega-3 PUFAs in neurobiological health? Eur. Neuropsychopharmacol., 2016, 26, 546-561.
[24]
Raz, R.; Carasso, R.L.; Yehuda, S. The influence of short-chain essential fatty acids on children with attention-deficit/hyperactivity disorder: A double-blind placebo-controlled study. J. Child Adolesc. Psychopharmacol., 2009, 19, 167-177.
[25]
Perera, H.; Jeewandara, K.C.; Seneviratne, S.; Guruge, C. Combined ω3 and ω6 supplementation in children with attention-deficit hyperactivity disorder (ADHD) refractory to methylphenidate treatment: A double-blind, placebo-controlled study. J. Child Neurol., 2012, 27(6), 747-753.
[26]
Assareh, M.; Davari Ashtiani, R.; Khademi, M.; Jazayeri, S.; Rai, A.; Nikoo, M. Efficacy of Polyunsaturated Fatty Acids (PUFA) in the treatment of attention deficit hyperactivity disorder. J. Atten. Disord., 2012, 21(1), 78-85.
[27]
Manor, I.; Magen, A.; Keidar, D.; Rosen, S.; Tasker, H.; Cohen, T.; Richter, Y.; Zaaroor-Regev, D.; Manor, Y.; Weizman, A. The effect
of phosphatidylserine containing Omega3 fatty-acids on attention-
deficit hyperactivity disorder symptoms in children: a doubleblind
placebo-controlled trial, followed by an open-label extension Eur. Psychiat, 2012, 27(5), 335-342. ClinicalTrials.gov registration
number: NCT00418184.
[28]
Widenhorn-Müller, K.; Schwanda, S.; Scholz, E.; Spitzer, M.; Bode, H. Effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit/hyperactivity disorder (ADHD): A randomized placebo-controlled intervention trial. Prostaglandins Leukot. Essent. Fatty Acids, 2014, 91(1-2), 49-60.
[29]
Bos, D.J.; Oranje, B.; Veerhoek, E.S.; Van Diepen, R.M.; Weusten, J.M.; Demmelmair, H.; Koletzko, B. de Sain-var der Velden,
M.G.; Eilander, A.; Hoeksma, M.; Durston, S. Reduced symptoms
of inattention after dietary omega-3 fatty acid supplementation in
boys with and without attention deficit/hyperactivity disorder Neuropsychopharmacology, 2015, 40(10), 2298-2306. ClinicalTrials.
gov registration number: NCT01554462.
[30]
Groves, N.J.; Kesby, J.P.; Eyles, D.W.; McGrath, J.J.; Mackay-Sim, A.; Burne, T.H. Adult vitamin D deficiency leads to behavioural and brain neurochemical alterations in C57BL/6J and BALB/c mice. Behav. Brain Res., 2013, 241, 120-131.
[31]
Eyles, D.W.; Burne, T.H.; McGrath, J.J. Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front. Neuroendocrinol., 2013, 34(1), 47-64.
[32]
Landaas, E.T.; Aarsland, T.I.M.; Ulvik, A.; Halmøy, A.; Ueland, P.M.; Haavik, J. Vitamin levels in adults with ADHD. BJPsych Open, 2016, 2(6), 377-384.
[33]
Kamal, M.; Bener, A.; Ehlayel, M.S. Is high prevalence of vitamin D deficiency a correlate for attention deficit hyperactivity disorder? Atten. Defic. Hyperact. Disord., 2014, 6(2), 73-78.
[34]
Goksugur, S.B.; Tufan, A.E.; Semiz, M. Gunes. C.; Bekdas, M.; Tosun, M.; Demircioglu, F. Vitamin D status in children with attention deficit hyperactivity disorder. Pediatr. Int., 2014, 56(4), 515-519.
[35]
Elshorbagy, H.H.; Barseem, N.F.; Abdelghani, W.E.; Suliman, H.A.I.; Al-Shokary, A.H.; Abdulsamea, S.E.; Elsadek, A.E.; Abdel Maksoud, Y.H.; Nour El Din, D.M.A.E. The impact of vitamin D supplementation on attention-deficit hyperactivity disorder in children. Ann. Pharmacother., 2018.
[http://dx.doi.org/10.1177/1060028018759471]
[http://dx.doi.org/10.1177/1060028018759471]
[36]
Rucklidge, J.J.; Frampton, C.M.; Gorman, B.; Boggis, A. Vitaminmineral
treatment of attention-deficit hyperactivity disorder in
adults: double-blind randomised placebo-controlled trial Br J Psychiatry, 2014, 204, 306-315. Australian New Zealand Clinical Trials
Registry: ACTRN12609000308291.
[37]
Pelsser, L.M.; Frankena, K.; Toorman, J.; Savelkoul, H.F.; Dubois, A.E.; Pereira, R.R.; Haagen, T.A.; Rommelse, N.N.; Buitelaar, J.K. Effects of a restricted elimination diet on the behaviour of children
with attention-deficit hyperactivity disorder (INCA study): A randomised
controlled trial Lancet,, 2011, 377(9764), 494-503. International
Standard Randomised Controlled Trial, number ISRCTN
76063113.
[38]
Nigg, J.T.; Lewis, K.; Edinger, T.; Falk, M. Meta-analysis of attention- deficit/hyperactivity disorder or attention-deficit/hyperactivity disorder symptoms, restriction diet, and synthetic food color additives. J. Am. Acad. Child Adolesc. Psychiatry, 2012, 51(1), 86-97.e8.
[39]
Sonuga-Barke, E.J.; Brandeis, D.; Cortese, S.; Daley, D.; Ferrin, M.; Holtmann, M.; Stevenson, J.; Danckaerts, M.; van der Oord, S.; Döpfner, M.; Dittmann, R.W.; Simonoff, E.; Zuddas, A.; Banaschewski, T.; Buitelaar, J.; Coghill, D.; Hollis, C.; Konofal, E.; Lecendreux, M.; Wong, I.C.; Sergeant, J. European ADHD Guidelines Group. Nonpharmacological interventions for ADHD: Systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am. J. Psychiatry, 2013, 170(3), 275-289.
[40]
Pelsser, L.M.; Frankena, K.; Toorman, J.; Savelkoul, H.F.; Pereira, R.R.; Buitelaar, J.K. A randomised controlled trial into the effects of food on ADHD. Eur. Child Adolesc. Psychiatry, 2009, 18(1), 12-19.
[41]
Donini, L.M.; Serra-Majem, L.; Bulló, M.; Gil, Á.; Salas-Salvadó, J. The Mediterranean diet: culture, health and science. Br. J. Nutr., 2015, 113(Suppl. 2), S1-S3.
[42]
Davis, C.; Bryan, J.; Hodgson, J.; Murphy, K. Definition of the Mediterranean diet: A literature review. Nutrients, 2015, 7(11), 9139-9153.
[43]
Ríos-Hernández, A.; Alda, J.A.; Farran-Codina, A.; Ferreira-García, E.; Izquierdo-Pulido, M. The Mediterranean diet and ADHD in children and adolescents. Pediatrics, 2017, 139(2)
[44]
San Mauro Martín, I.; Blumenfeld Olivares, J.A.; Vilar, G.E.; López, E.M.; Bernat, G.M.; Santos, Q.Y.; López, B.M.; Pascual, E.P.; Rivilla, B.E.; Barrado, R.M. Nutritional and environmental factors in attention-deficit hyperactivity disorder (ADHD): A cross-sectional study. Nutr. Neurosci., 2017, 1 -7 .
[http://dx.doi.org/10.1080/ 1028415X.2017.1331952]
[http://dx.doi.org/10.1080/ 1028415X.2017.1331952]
[45]
Holton, K.F.; Nigg, J.T. The association of lifestyle factors and ADHD in children. J. Atten. Disord., 2016, 1087054716646452.
[46]
Zhou, F.; Wu, F.; Zou, S.; Chen, Y.; Feng, C.; Fan, G. Dietary, nutrient patterns and blood essential elements in chinese children with ADHD. Nutrients, 2016, 8, 352.
[47]
Holton, K.F.; Johnstone, J.M.; Brandley, E.T.; Nigg, J.T. Evaluation of dietary intake in children and college students with and without attention-deficit/hyperactivity disorder. Nutr. Neurosci., 2018, •••, 1-14.
[48]
Sinn, N.; Bryan, J.; Wilson, C. Cognitive effects of polyunsaturated fatty acids in children with attention deficit hyperactivity disorder symptoms: a randomised controlled trial. Prostaglandins Leukot. Essent. Fatty Acids, 2008, 78(4-5), 311-326.
[49]
Bélanger, S.A.; Vanasse, M.; Spahis, S.; Sylvestre, M.P.; Lippé, S.; L’heureux, F.; Ghadirian, P.; Vanasse, C.M.; Levy, E. Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: A randomized, double-blind, placebo-controlled study. Paediatr. Child Health, 2009, 14(2), 89-98.
[50]
Johnson, M.; Ostlund, S.; Fransson, G.; Kadesjö, B.; Gillberg, C. Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents. J. Atten. Disord., 2009, 12(5), 394-401.
[51]
Kirby, A.; Woodward, A.; Jackson, S.; Wang, Y.; Crawford, M.A. A double-blind, placebo-controlled study investigating the effects of omega-3 supplementation in children aged 8-10 years from a mainstream school population. Res. Dev. Disabil., 2010, 31(3), 718-730.
[52]
Milte, C.M.; Parletta, N.; Buckley, J.D.; Coates, A.M.; Young, R.M.; Howe, P.R. Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/ hyperactivity disorder: A randomized controlled trial. Nutrition, 2012, 28(6), 670-677.
[53]
Gustafsson, P.A.; Birberg-Thornberg, U.; Duchén, K.; Landgren, M.; Malmberg, K.; Pelling, H.; Strandvik, B.; Karlsson, T. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD. Acta Paediatr., 2010, 99(10), 1540-1549.
[54]
Bloch, M.H.; Qawasmi, A. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: Systematic review and meta-analysis. J. Am. Acad. Child Adolesc. Psychiatry, 2011, 50(10), 991-1000.
[55]
Holick, M.F.; Binkley, N.C.; Bischoff-Ferrari, H.A.; Gordon, C.M.; Hanley, D.A.; Heaney, R.P.; Murad, M.H.; Weaver, C.M. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab., 2011, 96(7), 1911-1930.
[56]
Sharif, M.R.; Madani, M.; Tabatabaei, F.; Tabatabaee, Z. The relationship between serum vitamin D level and attention deficit hyperactivity disorder. Iran. J. Child. Neurol., 2015, 9(4), 48-53.
[57]
Shang-Guan, L.L.; Zhao, Y.R. Serum levels of 25-hydroxyvitamin D in children with attention deficit hyperactivity disorder. Zhongguo Dang Dai Er Ke Za Zhi, 2015, 17(8), 837-840.
[58]
Tolppanen, A.M.; Sayers, A.; Fraser, W.; Lewis, G.; Zammit, S.; Lawlor, D.A. The association of 25-hydroxyvitamin D3 and D2 with behavioural problems in childhood. PLoS One, 2012, 7(7), e40097.
[59]
Rucklidge, J.J.; Johnstone, J.; Gorman, B.; Boggis, A.; Frampton, C.M. Moderators of treatment response in adults with ADHD treated with a vitamin-mineral supplement. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2014, 50, 163-171.
[60]
Kim, Y.; Chang, H. Correlation between attention deficit hyperactivity disorder and sugar consumption, quality of diet, and dietary behavior in school children. Nutr. Res. Pract., 2011, 5(3), 236-245.
[61]
Park, S.; Cho, S.C.; Hong, Y.C.; Oh, S.Y.; Kim, J.W.; Shin, M.S.; Kim, B.N.; Yoo, H.J.; Cho, I.H.; Bhang, S.Y. Association between dietary behaviors and attention-deficit/hyperactivity disorder and learning disabilities in school-aged children. Psychiatry Res., 2012, 198(3), 468-476.
Call for Papers in Thematic Issues
01 June, 2024
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
Related Journals
Anti-Cancer Agents in Medicinal Chemistry
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Bioactive Compounds
Current Cancer Drug Targets
Combinatorial Chemistry & High Throughput Screening
Current Cancer Therapy Reviews
Current Diabetes Reviews
Current Drug Safety
Current Drug Targets
Current Drug Therapy
Related Books
Drug Addiction Mechanisms in the Brain
Software and Programming Tools in Pharmaceutical Research
Objective Pharmaceutics: A Comprehensive Compilation of Questions and Answers for Pharmaceutics Exam Prep
Medicinal Chemistry of Drugs Affecting Cardiovascular and Endocrine Systems
Research Methodology and Project Management in Biotechnology
Recent Progress in Pharmaceutical Nanobiotechnology: A Medical Perspective
Medicinal Plants, Phytomedicines and Traditional Herbal Remedies for Drug Discovery and Development against COVID-19
Advanced Pharmacy
Plant-derived Hepatoprotective Drugs
The Role of Chromenes in Drug Discovery and Development
Article Metrics
91
15
2